Asia Pacific Pharmacokinetics Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)

No. of Pages: 95    |    Report Code: BMIRE00030886    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Pharmacokinetics Services Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Pharmacokinetics Services Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Pharmacokinetics Services Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic and Infectious Diseases Drives the Pharmacokinetics Services Market
5.2 Market Opportunities
  • 5.2.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics is the opportinity in the Pharmacokinetics Services Market
5.3 Future Trends
  • 5.3.1 Expanding Range of Application of Pharmacokinetic Studies Drives the Pharmacokinetics Services Market
5.4 Impact of Drivers and Restraints

6. Asia Pacific Pharmacokinetics Services Market Regional Analysis

6.1 Asia Pacific Pharmacokinetics Services Market Overview
6.2 Asia Pacific Pharmacokinetics Services Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Pharmacokinetics Services Market Forecast Analysis

7. Asia Pacific Pharmacokinetics Services Market Analysis – by Drug Type

7.1 Small Molecule
  • 7.1.1 Overview
  • 7.1.2 Small Molecule: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Large Molecule
  • 7.2.1 Overview
  • 7.2.2 Large Molecule: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vaccines
  • 7.3.1 Overview
  • 7.3.2 Vaccines: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Pharmacokinetics Services Market Analysis – by Service Type

8.1 Pre-Clinical ADME and Human Studies
  • 8.1.1 Overview
  • 8.1.2 Pre-Clinical ADME and Human Studies: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 PK/PD Analysis and Reporting
  • 8.2.1 Overview
  • 8.2.2 PK/PD Analysis and Reporting: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Dosing Simulations
  • 8.3.1 Overview
  • 8.3.2 Dosing Simulations: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Risk Analysis
  • 8.4.1 Overview
  • 8.4.2 Risk Analysis: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Pharmacokinetics Services Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Risk Analysis: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
  • 9.2.1 Overview
  • 9.2.2 Risk Analysis: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Pharmacokinetics Services Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Pharmacokinetics Services Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.1.2 China: Asia Pacific Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.1.3 China: Asia Pacific Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.2.2 India: Asia Pacific Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.2.3 India: Asia Pacific Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.3.2 Japan: Asia Pacific Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.3.3 Japan: Asia Pacific Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.4.2 Australia: Asia Pacific Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.4.3 Australia: Asia Pacific Pharmacokinetics Services Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmacokinetics Services Market Breakdown, by Drug Type
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmacokinetics Services Market Breakdown, by Service Type
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharmacokinetics Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Pharmacokinetics Services Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allucent
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Certara Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Charles River Laboratories International Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Eurofins Scientific SE
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 PACIFIC BIOLABS
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Parexel International Corp
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 SGS SA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Shanghai Medicilon Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Allucent
  2. Certara Inc.
  3. Charles River Laboratories International Inc
  4. Eurofins Scientific SE
  5. PACIFIC BIOLABS
  6. Parexel International Corp
  7. SGS SA
  8. Shanghai Medicilon Inc.
  9. Thermo Fisher Scientific Inc.
asia-pacific-pharmacokinetics-services-market